...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Priceless on I.V. Regarding Zenith

SF

Thanks for sharing the information on Zenith Enigmatic, the mystical benefactor of RVX future royalties.

Not being insiders is most difficult for minority shareholders holding an interest in a non public company.

Hopefully the trial is progressing well and results are promising and we will get news soon.

I do believe that RVXs spinoff of Zenith and the company's award of a future revenue stream of 6-8% of all future RVX net revenues has hindered RVXs marketability. What was the real motive? Who was the architect? Why did DM tout a ZEN Market Cap of $500MM? What happened to the IPO, reverse IPO, BP partnership? 

And so many more questions -

So we patiently wait for enlightenment - 

My business responsibilites are pressing me right now and I don't have much time to correspond but I do keep current on everyones posts and the Agoracom daily digest is a helpful feature and reminder. 

Best Wishes to All,

Chicagoest 

Share
New Message
Please login to post a reply